No Data Yet
Thermo Fisher Scientific launched its PPD CorEvitas Alzheimer's Disease Registry on December 18, 2025, to generate real-world evidence on drug safety and effectiveness for the growing patient population.
The global microplastic analysis market is forecast to grow from $266.9 million in 2025 to $383.1 million by 2030, a 7.5% CAGR, driven by increasing regulatory pressure and health risk awareness.
Thermo Fisher Scientific has launched two new chemically defined media to enhance the productivity of E. coli-based manufacturing. This move addresses the growing demand for scalable production of plasmid DNA and recombinant proteins, which are critical components for gene therapies and mRNA vaccines.
Morgan Stanley initiates coverage on Thermo Fisher Scientific (TMO) with a bullish Overweight rating and an increased price target of $670. The action reflects institutional confidence in the life sciences company's market position and future performance.
A new report projects the global blood collection tubes market will reach $7.23 billion by 2032, driven by personalized medicine. However, this optimistic forecast is set against a backdrop of significant regulatory uncertainty at the U.S. Food and Drug Administration (FDA), creating a complex risk environment for key industry players like Becton Dickinson, Bio-Rad, and Thermo Fisher Scientific.